Hyunjoon Kim

Hyunjoon Kim is an Assistant Professor in the Department of Pharmaceutical Chemistry at the University of Kansas School of Pharmacy. His research focuses on developing translational drug delivery platforms for biopharmaceuticals and immunotherapies, with expertise in nano/microparticle formulations and immune system modulation.

• Postdoctoral Associate in Immunoengineering at MIT (2022)
• Ph.D. in Pharmaceutics from the University of Minnesota (2018)
• M.Pharm and B.Pharm in Pharmacy from Kyungsung University (South Korea)

Kim's research emphasizes overcoming challenges in biopharmaceutical delivery through:

• Designing nano/microparticle and scaffold-based drug delivery systems
• Engineering biomaterials to modulate immune responses
• Developing high-throughput screening assays
• Testing immunotherapies in cancer and chronic disease models

His publications highlight innovations in TLR7/8 agonist delivery systems and implantable devices for urological applications, demonstrating expertise in:

• Cancer immunotherapy platforms
• pH-responsive polymer nanoparticles
• Combination therapy delivery systems
• Biodegradable medical devices